Drug-induced interstitial lung disease in the treatment of malignant lymphoma as a potential diagnostic marker: a comparison of serum Krebs von Lungen-6 and thymus and activation-regulated chemokine/CC chemokine ligand 17

References

• SaitoYGemmaACurrent status of DILD in molecular targeted therapiesInt J Clin Oncol201217653454123152005
   PubMed Web of Science ®Google Scholar
• CamusPKudohSEbinaMInterstitial lung disease associated with drug therapyBr J Cancer200491Suppl 2S18S2315340374
   PubMed Web of Science ®Google Scholar
• HottaKKiuraKTakigawaNComparison of the incidence and pattern of interstitial lung disease during erlotinib and gefitinib treatment in Japanese Patients with non-small cell lung cancer: the Okayama Lung Cancer Study Group experienceJ Thorac Oncol20105217918420101144
   PubMed Web of Science ®Google Scholar
• ShahDJSachsRKWilsonDJRadiation-induced cancer: a modern viewBr J Radiol2012851020e1166e117323175483
   PubMed Web of Science ®Google Scholar
• KohnoNKyoizumiSAwayaYFukuharaHYamakidoMAkiyamaMNew serum indicator of interstitial pneumonitis activity. Sialylated carbohydrate antigen KL-6Chest198996168732661160
   PubMed Web of Science ®Google Scholar
• SakamotoKTaniguchiHKondohYSerum KL-6 in fibrotic NSIP: Correlations with physiologic and radiologic parametersRespir Med2010104112713319811899
   PubMed Web of Science ®Google Scholar
• OhnishiHYokoyamaAKondoKComparative study of KL-6, surfactant protein-A, surfactant protein-D, and monocyte chemoattractant protein-1 as serum markers for interstitial lung diseasesAm J Respir Crit Care Med2002165337838111818324
   PubMed Web of Science ®Google Scholar
• MiyazakiENurekiSFukamiTElevated levels of thymus- and activation-regulated chemokine in bronchoalveolar lavage fluid from patients with eosinophilic pneumoniaAm J Respir Crit Care Med200216581125113111956056
   PubMed Web of Science ®Google Scholar
• BelperioJADyMMurrayLThe role of the Th2 CC chemokine ligand CCL17 in pulmonary fibrosisJ Immunol200417374692469815383605
   PubMed Web of Science ®Google Scholar
• MiyazakiENurekiSOnoECirculating thymus- and activation-regulated chemokine/CCL17 is a useful biomarker for discriminating acute eosinophilic pneumonia from other causes of acute lung injuryChest200713161726173417565019
   PubMed Web of Science ®Google Scholar
• JonesKVariFKeaneCSerum CD163 and TARC as disease response biomarkers in classical Hodgkin lymphomaClin Cancer Res201319373174223224400
   PubMed Web of Science ®Google Scholar
• YamaneHOchiNYamagishiTHondaYTakeyamaMTakigawaNCirculating thymus and activation-regulated chemokine/CC chemokine ligand 17 is a strong candidate diagnostic marker for interstitial lung disease in patients with malignant tumors: a result from a pilot studyTher Clin Risk Manag20151194995926124663
   PubMed Web of Science ®Google Scholar
• TravisWDCostabelUHansellDMAn official American Thoracic Society/European Respiratory Society statement: Update of the international multidisciplinary classification of the idiopathic interstitial pneumoniasAm J Respir Crit Care Med2013188673374824032382
   PubMed Web of Science ®Google Scholar
• WebbWRMüllerNLNaidichDPHigh-Resolution CT of the Lung3rd edPhiladelphiaLippincott Williams & Wilkins2001
   Google Scholar
• KakinumaTWakugawaMNakamuraKHinoHMatsushimaKTamakiKHigh level of thymus and activation-regulated chemokine in blister fluid and sera of patients with bullous pemphigoidBr J Dermatol2003148220321012588369
   PubMed Web of Science ®Google Scholar
• International Non-Hodgkin’s Lymphoma Prognostic Factors ProjectA predictive model for aggressive non-Hodgkin’s lymphomaN Engl J Med1993329149879948141877
   PubMed Web of Science ®Google Scholar
• SalmasiGLiMSivabalasundaramVIncidence of pneumonitis in patients with non-Hodgkin lymphoma receiving chemoimmunotherapy with rituximabLeuk Lymphoma20155661659166425356925
   PubMed Web of Science ®Google Scholar
• LiuWPWangXPZhengWIncidence, clinical characteristics, and outcome of interstitial pneumonia in patients with lymphomaAnn Hematol201897113313929086010
   PubMed Web of Science ®Google Scholar
• HuangYCLiuCJLiuCYLow absolute lymphocyte count and addition of rituximab confer high risk for interstitial pneumonia in patients with diffuse large B-cell lymphomaAnn Hematol201190101145115121647583
   PubMed Web of Science ®Google Scholar
• IshikawaNHattoriNYokoyamaAKohnoNUtility of KL-6/MUC1 in the clinical management of interstitial lung diseasesRespir Investig2012501313
   PubMedGoogle Scholar
• FujiwaraYKiuraKToyookaSElevated serum level of sialylated glycoprotein KL-6 predicts a poor prognosis in patients with non-small cell lung cancer treated with gefitinibLung Cancer2008591818717765355
   PubMed Web of Science ®Google Scholar
• KobayashiHKanohSMotoyoshiKSerum surfactant protein-A, but not surfactant protein-D or KL-6, can predict preclinical lung damage induced by smokingBiomarkers200813438539218595202
   PubMed Web of Science ®Google Scholar
• Feghali-BostwickCATsaiCGValentineVGCellular and humoral autoreactivity in idiopathic pulmonary fibrosisJ Immunol200717942592259917675522
   PubMed Web of Science ®Google Scholar
• ZuoFKaminskiNEuguiEGene expression analysis reveals matrilysin as a key regulator of pulmonary fibrosis in mice and humansProc Natl Acad Sci U S A20029996292629711983918
   PubMed Web of Science ®Google Scholar
• KurosuKTakiguchiYOkadaOIdentification of annexin 1 as a novel autoantigen in acute exacerbation of idiopathic pulmonary fibrosisJ Immunol2008181175676718566442
   PubMed Web of Science ®Google Scholar
• BorchersATChangCKeenCLGershwinMEIdiopathic pulmonary fibrosis-an epidemiological and pathological reviewClin Rev Allergy Immunol201140211713420838937
   PubMed Web of Science ®Google Scholar
• WallaceWARamageEALambDHowieSEA type 2 (Th2-like) pattern of immune response predominates in the pulmonary interstitium of patients with cryptogenic fibrosing alveolitis (CFA)Clin Exp Immunol199510134364417664490
   PubMed Web of Science ®Google Scholar
• OhnishiHYokoyamaAYasuharaYCirculating KL-6 levels in patients with drug induced pneumonitisThorax2003581087287514514942
   PubMed Web of Science ®Google Scholar
• RitterMGöggelRChaudharyNElevated expression of TARC (CCL17) and MDC (CCL22) in models of cigarette smoke-induced pulmonary inflammationBiochem Biophys Res Commun2005334125426215993846
   PubMed Web of Science ®Google Scholar